TrialCancer biology & medicine2025

Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma.

Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.